⌘K

Home/Filings/4/0001493152-22-027441

4//SEC Filing

Karah Hila 4

Accession 0001493152-22-027441

CIK 0001857044other

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:31 PM ET

Size

5.3 KB

Accession

0001493152-22-027441

Insider Transaction Report

Form 4

Period: 2022-09-30

Indaptus Therapeutics, Inc.INDP

Director

Transactions

Award
Stock Option (right to buy)
2022-09-30+13,750→ 13,750 total
Exercise: $2.16Exp: 2032-09-30→ Common Stock (13,750 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable on September 30, 2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1

filerCIK 0001668116

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 4:31 PM ET
Size: 5.3 KB

View on SEC.gov